Form EFFECT Tonix Pharmaceuticals
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 4, 2025 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NutroBlaze Launches Seed-based Snack Blends in a Bottle
- Corza Medical Launches Expanded Blink Single-Use Custom Packs and First-of-Its-Kind Microsurgical Knife Manufacturing Process
- Emdoor Information Marks 18 Years of Rugged Computing Excellence with Vertically Integrated Capabilities
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share